TLDR: PubHive has launched a new Generative AI Usage Dashboard, providing life sciences organizations with greater transparency, governance, cost management, and audit-ready compliance for their AI initiatives.
LONDON, UNITED KINGDOM – September 29, 2025 – PubHive, an award-winning AI-powered SaaS platform specializing in scientific literature and safety information management, today announced the introduction of its Generative AI Usage Dashboard. This innovative solution is designed to address the growing need within the life sciences sector for robust governance, cost efficiency, and compliance in the deployment and utilization of generative artificial intelligence.
The new dashboard offers life sciences teams unprecedented transparency into their generative AI operations. As AI adoption accelerates across research and development, medical affairs, pharmacovigilance, and regulatory functions, organizations face increasing challenges in monitoring AI tool usage, managing associated costs, and ensuring adherence to internal policies and external regulations.
The Generative AI Usage Dashboard aims to provide a centralized view of AI activities, enabling companies to:
Enhance Transparency: Gain clear insights into who is using generative AI tools, for what purposes, and the volume of usage.
Strengthen Governance: Implement and enforce policies related to AI use, data privacy, and ethical considerations, ensuring responsible AI deployment.
Optimize Cost Efficiency: Track and analyze expenditures associated with generative AI, allowing for better budget allocation and identification of cost-saving opportunities.
Ensure Audit-Ready Compliance: Maintain comprehensive records of AI usage, facilitating easier audits and demonstrating compliance with industry standards and regulatory requirements.
This launch underscores PubHive’s commitment to empowering life sciences organizations with advanced, AI-driven solutions that not only streamline complex workflows but also provide the necessary controls for emerging technologies. The company has been recognized for its innovative approach, including being named “Best Scientific Literature Platform 2025” by SME News for transforming scientific literature workflows with AI-powered automation. PubHive’s existing portfolio includes solutions like AI-Insight, a generative AI tool for personalized literature reviews, and advanced signal detection capabilities in pharmacovigilance, all powered by its proprietary Omni-Loop Artificial Intelligence (AI)™ engine.
Also Read:
- QInscribe Launches AI-Powered Medical Writing Service, Dramatically Accelerating Clinical Study Report Generation
- GoodData Unveils Next-Generation Full-Stack Data Intelligence Platform with Advanced AI Integration
The Generative AI Usage Dashboard is expected to become a critical tool for life sciences companies navigating the complexities of AI integration, offering a strategic advantage in managing their AI footprint effectively and responsibly.
